Fulcrum Therapeutics, Inc. (FULC)
10.06
+0.21
(+2.13%)
USD |
NASDAQ |
Jan 12, 09:41
Fulcrum Therapeutics Accounts Payable (Quarterly): 2.856M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 19.55M |
| Biogen, Inc. | 413.10M |
| CorMedix, Inc. | 20.45M |
| Apellis Pharmaceuticals, Inc. | 38.60M |
| NovaBay Pharmaceuticals, Inc. | 0.076M |